Cytek Biosciences, Inc. · NASDAQ:CTKB
BlackRock, Inc. reported a 7.20% stake in Cytek Biosciences, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Jul 8, 2026
BlackRock, Inc. reported a 7.20% stake in Cytek Biosciences, Inc., 9,356,551 shares, as a passive investor on Jun 30, 2026. Filed Jul 8, 2026 (Schedule 13G/A).
- Stake
- 7.20%
- Shares
- 9,356,551
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 7.20% | 9,356,551 |
Source
Related
- Cytek Biosciences, Inc.
- BlackRock, Inc.
- Cytek Biosciences, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Jul 18, 2025
- Schedule 13G/A · BlackRock, Inc. · Feb 5, 2025
- Form 4 · Jiang Wenbin · Aug 20, 2026
- Form 4 · McCombe William D. · Aug 20, 2026
- Form 4 · Muir Glenn P · Aug 20, 2026
- Form 4 · Holder Michael · Aug 20, 2026
- Form 4 · Chin Richard · Aug 20, 2026